BenzingaFri, 08 May 2026 13:34:41 GMTCapricor Therapeutics Says NS Pharma Delays Could Threaten Access To Duchenne TherapyCAPR-10.49%
BenzingaTue, 10 Mar 2026 14:47:25 GMTCapricor Therapeutics Stock Jumps As FDA Resumes Deramiocel ReviewCAPR-10.49%